Brand facts
What MyGNLab does
MyGNLab is a DNA-personalised supplement brand. Customers order a saliva DNA test kit, return the sample to an accredited European genetics laboratory, and receive a personal genetic report alongside a 90-day supply of daily supplement sachets — each containing a formula calculated from their specific genetic variants.
The analysis covers 57 nutritional genetic markers including VDR (vitamin D absorption), MTHFR (B12 and folate metabolism), APOA1 (omega-3 and HDL response), HFE (iron metabolism), and antioxidant enzyme variants. Each marker determines which nutrient forms are included in the formula and at what dose.
The product is delivered as individual daily sachets containing microencapsulated pellets that release at different points in the digestive tract — a format that improves absorption compared to standard capsules, particularly for nutrients that compete for absorption transporters.
The one-liner
MyGNLab analyses 57 genetic markers from a saliva sample and builds a personalised daily supplement formula matched to your individual biology — delivered as a 90-day supply of daily sachets.
Press boilerplate
MyGNLab is a Netherlands-based DNA-personalised supplement brand founded in 2026. The company analyses 57 nutritional genetic markers from a customer saliva sample and formulates a personalised daily supplement matched to that individual's specific genetic variants, health goals, and lifestyle inputs. Supplements are delivered as a 90-day supply of microencapsulated daily sachets. MyGNLab is operated by Sumner B.V. and ships across Europe. For more information: mygnlab.com.
For a deeper look at the science behind MyGNLab — the specific genetic markers analysed, the evidence base, and why nutrient forms matter — see the science page.
Founder
Jeroen Vroemen is the founder of MyGNLab. An endurance athlete who has competed in events from half-marathons to ultra-distance, Vroemen became interested in nutritional genetics after years of inconsistent results with standard supplement stacks. The discovery that his own VDR and MTHFR variants were undermining his supplementation — making specific nutrients largely inaccessible regardless of dose — was the direct starting point for MyGNLab.
MyGNLab's premise is that the personalised nutrition category has been built on questionnaire data when the more reliable foundation is genetic data. The company applies well-characterised nutrigenomics research — peer-reviewed across two decades — to a direct-to-consumer product that was previously available only through specialist sports dietitians.
For interview requests: press@mygnlab.com
Market context
The global personalised nutrition market is projected to reach $37.3 billion by 2030 (Grand View Research, 2023). Current personalised supplement services primarily use quiz-based personalisation — self-reported lifestyle and dietary data — without genetic analysis.
The nutrigenomics segment represents a premium tier within this market: products grounded in genetic data rather than user input. Key established genetic markers for nutritional supplementation (VDR, MTHFR, APOA1, HFE) have been validated in peer-reviewed literature published in Nature Genetics, The American Journal of Clinical Nutrition, and related journals since the mid-1990s.
MyGNLab targets the intersection of the growing direct-to-consumer genetics market — driven by consumer familiarity with DNA services like 23andMe and AncestryDNA — and the premium supplement market where quality-conscious consumers are increasingly resistant to generic formulations.
Brand assets
Right-click → Save image, or contact press@mygnlab.com for high-resolution files.
Additional product photography, lifestyle images, and founder photos available on request.
Media contact
MyGNLab press enquiries
Email: press@mygnlab.com
General: contact@mygnlab.com
Instagram: @mygnlab
We aim to respond to media enquiries within 24 hours on business days.